114 recalls tagged with “nhtsa regulated”.
Honda recalled certain 2021-2025 Acura TLX, 2023-2025 Acura MDX, and 2023-2025 Honda Pilot vehicles due to a brake pedal defect. The brake pedal pivot pin may not be secured properly, increasing the risk of a crash. Owner notification letters were mailed on July 29, 2025.
BMW of North America recalled certain 2025 X3 30 xDrive and X3 M50 xDrive vehicles due to leaking rear brake hoses. This defect may lead to a loss of rear braking function and the failure of the Antilock Brake System and Dynamic Stability Control. Owners will receive notification letters mailed on May 9, 2025.
Volkswagen Group of America recalled certain 2025 Atlas and Atlas Cross Sport vehicles due to a manufacturing defect. The defect may cause a sudden loss of drive power, increasing crash risk. Notification letters were mailed on March 12, 2025.
Ford Motor Company recalled the 2025 Explorer on November 8, 2025. The recall affects vehicles with fuel injectors potentially lacking O-ring support discs. A fuel leak could increase the risk of fire.
Nivagen Zinc Oxide Ointment 20% skin protectant, manufactured in India for Nivagen Pharmaceuticals and distributed nationwide in the USA, is recalled. The recall covers 912 containers. The defect cited is cGMP deviations. Consumers and healthcare providers should stop using the product and follow guidance from Blossom Pharmaceuticals or a healthcare professional.
Paragon 28 recalled 20 units of its fibula nail system on October 13, 2025. The recall affects devices with out-of-specification thread depths, risking surgical complications. Patients and healthcare providers must stop using the affected devices immediately.
Volkswagen recalled certain 2025 ID. Buzz vehicles on October 4, 2025. The brake system warning light may display incorrect symbols and colors. This defect increases the risk of a crash.
Philips Ultrasound recalled 1 unit of the S5-2 Ultrasound Transducer sold nationwide through healthcare distributors. The recall clarifies labeling to define the useful life of the transducer in the field. Healthcare providers should stop using the device and contact Philips Ultrasound for instructions.
Philips recalled 17 units of the 3D6-2 Ultrasound Transducer distributed nationwide to healthcare facilities in the United States. The recall seeks to clarify labeling defining the transducer’s useful life. Clinicians and facilities should stop using the device immediately and follow Philips recall instructions.
Philips Ultrasound recalled 17 X3-1 ultrasound transducers nationwide in the United States. The recall is to provide clarification and labeling to define the useful life of transducers in the field. Healthcare providers and patients should stop using the affected devices immediately and await further manufacturer instructions.
Major Pharmaceuticals recalled 26,628 cartons of Carvedilol Tablets on August 20, 2025. The recall stems from N-Nitroso Carvedilol Impurity-1 levels exceeding FDA limits. Consumers should stop using the product immediately and consult their healthcare provider.
Maquet Cardiovascular recalled the Heartstring III Proximal Seal System on August 15, 2025, due to three identified failure modes. These failures include issues with the seal's loading, deployment, and hemostasis. The recall affects 168 units distributed worldwide.
Summa Therapeutics recalled 22 units of the Finesse BTK Multicath Injectable Angioplasty Balloon Catheter sold to healthcare facilities in New Jersey and Florida. The balloon may not meet burst specifications, raising risk during angioplasty. Healthcare providers must stop using the device immediately and follow recall instructions from Summa Therapeutics.
Omnia Medical recalled 15 units of the TiBrid Stand Alone Intervertebral Body Fusion Device on July 15, 2024. The recall affects devices distributed nationwide across six states due to potential failure of fusion system instruments. Patients and healthcare providers must stop using the devices immediately to avoid high-risk complications.